{"id":"W1969523085","doi":"10.1586/ern.13.12","title":"Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance","year":2013,"lang":"en","type":"review","venue":"Expert Review of Neurotherapeutics","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pharmacovigilance; Natalizumab; Medicine; Glatiramer acetate; Intensive care medicine; Fingolimod; Teriflunomide; Clinical trial; Disease; Mitoxantrone; Pregnancy; Multiple sclerosis; Drugs in pregnancy; Pharmacology; Drug; Psychiatry; Internal medicine; Fetus","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003413081,0.0004760001,0.002411645,0.0001168512,0.00008661911,0.000006001352,0.0001904791,0.0001938676,0.00001953839],"category_scores_gemma":[0.0002077024,0.0003591843,0.0005612298,0.00009495607,0.0001557026,0.00008247325,0.0000497258,0.0002363658,0.000002664313],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003508723,"about_ca_system_score_gemma":0.0001437126,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001914789,"about_ca_topic_score_gemma":0.000001017718,"domain_scores_codex":[0.9970499,0.0008417652,0.00110988,0.0006693212,0.00005130198,0.0002778144],"domain_scores_gemma":[0.996439,0.001933035,0.0008452454,0.0005223777,0.0002283387,0.0000320396],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002719705,0.0001089461,0.000003108654,0.2203965,0.0002133416,1.195272e-7,0.0004283152,5.96596e-8,0.0001611112,0.0003690171,0.0001828311,0.7781095],"study_design_scores_gemma":[0.0009152316,0.0001177368,0.00002295489,0.2116953,0.0003774965,0.000004860638,0.00001714316,6.274747e-7,0.0001573171,0.00007891875,0.7863674,0.0002450097],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001125288,0.9836285,0.00009191802,0.0003045081,0.001109023,0.0142775,0.0005475408,0.00001787585,0.00002198515],"genre_scores_gemma":[0.00004356804,0.9921774,0.0002950701,0.00009560663,0.0001712816,0.007038288,0.00009412185,0.0000641411,0.00002053424],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7861846,"threshold_uncertainty_score":0.999886,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1442044626414005,"score_gpt":0.3855751333231084,"score_spread":0.2413706706817079,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}